MOLECULAR PHARMACEUTICS
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
MOLECULAR PHARMACEUTICS
Mol. Pharmaceutics
ISSN / eISSN
1543-8384 / 1543-8392
Aims and Scope
Molecular Pharmaceutics publishes original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. Modalities of interest include small molecules, imaging agents, proteins, peptides, vaccines, cell and gene-based therapies, and their characterization, formulation, and delivery. Scientific areas within the scope of the journal include:
Modelling and simulation to aid mechanistic insights into drug delivery
Molecular understanding of formulations
Formulation performance under physiological conditions
Materials science as it relates to drug, excipients and drug delivery system efficacy.
Emerging techniques and technologies for drug delivery including theranostics, precision medicine and artificial intelligence
Theoretical and experimental peer-reviewed full-length research papers, critical reviews, perspectives, and communications are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.
Modelling and simulation to aid mechanistic insights into drug delivery
Molecular understanding of formulations
Formulation performance under physiological conditions
Materials science as it relates to drug, excipients and drug delivery system efficacy.
Emerging techniques and technologies for drug delivery including theranostics, precision medicine and artificial intelligence
Theoretical and experimental peer-reviewed full-length research papers, critical reviews, perspectives, and communications are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.
Subject Area
PHARMACOLOGY & PHARMACY
MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
9.20
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science | Q1 | #24/171 |
| Pharmacology, Toxicology and Pharmaceutics - Drug Discovery | Q1 | #26/156 |
| Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine | Q1 | #40/171 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| MEDICINE, RESEARCH & EXPERIMENTAL - SCIE | Q2 |
| PHARMACOLOGY & PHARMACY - SCIE | Q1 |
H-index
110
Country/Area of Publication
UNITED STATES
Publisher
American Chemical Society
Publication Frequency
Monthly
Year Publication Started
2004
Annual Article Volume
440
Open Access
NO
Contact
AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, USA, DC, 20036
Verified Reviews
In the first month, one rejection, one major revision, and four minor revisions.
Two months later, the revised manuscript was submitted.
Another month passed with two minor revisions and four approvals.
In the final week, the revisions were completed and accepted directly.
In total, it took four months from start to finish.
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now